Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 766 of 1,261
  1. US 8962685

    Creatine oral supplementation using creatine hydrochloride salt

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  2. US 8962835

    Imidazopyrazine Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  3. US 8961996

    N-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  4. US 8962297

    Bacteriophage lytic enzymes as alternative antimicrobials

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  5. US 8962588

    Micro-RNAS that control myosin expression and myofiber identity

    The Board of Regents of the University of Texas System · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  6. US 8961989

    Methods for producing an immune response to tuberculosis

    The United States of America as represented by the Department of Veteran Affairs · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  7. US 8962026

    Nanoemulsion therapeutic compositions and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  8. US 8962856

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  9. US 8962814

    Interleukin-1α antibodies and methods of use

    XBIOTECH INC. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  10. US 8962847

    Multicomponent crystals made of ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and an arylpropionic acid

    TEVA GmbH · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  11. US 8962797

    Halogenated compounds for photodynamic therapy

    NANOQUANTUM SCIENCES, INC. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  12. US 8962709

    Resin systems for dental restorative materials and methods using same

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  13. US 8962817

    Vectors encoding a paralytic peptide

    Soricimed Biopharma Inc. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  14. US 8962663

    Small molecule inhibitors of the pleckstrin homology domain and methods for using same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  15. US 8962642

    5-cyano-4- (pyrrolo [2,3B] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  16. US 8962677

    Methods of restoring cognitive ability using non-peptidic compounds

    Acumen Pharmaceuticals, Inc. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  17. US 8962643

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  18. US 8962631

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  19. US 8962593

    GLA monotherapy for use in cancer treatment

    IMMUNE DESIGN CORP. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  20. US 8962569

    Compositions comprising spp24 peptide fragments

    The Regents of the University of California · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  21. US 8962566

    Multi-arm polymeric alkanoate conjugates

    Nektar Therapeutics · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  22. US 8962561

    Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes

    The Fund for Medical Research, Development of Infrastructure and Health Services—Assaf HaRofeh Medical Center · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  23. US 8962551

    Quinoxalinyl derivatives

    Enanta Pharmaceuticals, Inc. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  24. US 8962531

    Development of a high-throughput screen for the identification of novel antifungal drug candidates

    The Board of Regents of the University of Texas System · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.